Stockscreener 앱 받기
21.26
3.89%
-0.86
시장 영업 전:
21.35
0.09
+0.42%
Summit Therapeutics Inc (SMMT) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Operating Expenses |
3.96%
224.93
|
234.21 | 568.44 | 66.85 | 65.82 |
| Nonoperating Income/Loss |
137.92%
5.753
|
2.418 | 2.729 | 3.938 | 13.10 |
| Income/Loss From Continuing Operations Before Tax |
5.44%
-219.17
|
-231.79 | -565.71 | -62.91 | -61.20 |
| Income/Loss From Continuing Operations After Tax |
5.44%
-219.17
|
-231.79 | -565.71 | -62.91 | -61.20 |
Net Income/Loss
|
5.44%
-219.17
|
-231.79 | -565.71 | -62.91 | -61.20 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.15%
6.3137
|
743.42 | 742.62 | 738.08 | 6.3735 |
| Diluted Average Shares |
99.15%
6.3137
|
743.42 | 742.62 | 738.08 | 6.3735 |
| Basic Earnings Per Share |
9.68%
-0.28
|
-0.31 | -0.76 | -0.09 | -0.09 |
| Diluted Earnings Per Share |
9.68%
-0.28
|
-0.31 | -0.76 | -0.09 | -0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.29%
0.00%
자본화:
|
볼륨(24시간):